Evidence map›Paper›PMID 27753679›Full record

ArticleAIDS (London, England)2016

Costs along the service cascades for HIV testing and counselling and prevention of mother-to-child transmission.

Sergio Bautista-Arredondo, Sandra G Sosa-Rubí, Marjorie Opuni, David Contreras-Loya, Ada Kwan, Claire Chaumont, Abson Chompolola, Jeanine Condo, Omar Galárraga, Neil Martinson and 6 more

Abstract read
In one paragraph

Article in AIDS (London, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Sergio Bautista-ArredondoaNational Institute of Public Health (INSP), Division of Health Economics, Cuernavaca, Mexico bUNAIDS, Geneva, Switzerland cDivision of Economics, University of Zambia, Lusaka, Zambia dNational University of Rwanda, School of Public Health, Kigali, Rwanda eBrown University, Providence, Rhode Island, USA fPerinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa gRwanda Biomedical Center, Kigali, Rwanda hNortheastern University, Boston, Massachusetts, USA iUniversity of Nairobi, School of Public Health, Nairobi, Kenya.
Sandra G Sosa-Rubí
Marjorie Opuni
David Contreras-Loya
Ada Kwan
Claire Chaumont
Abson Chompolola
Jeanine Condo
Omar Galárraga
Neil Martinson
Felix Masiye
Sabin Nsanzimana
Ivan Ochoa-Moreno
Richard Wamai
Joseph Wang'ombe
ORPHEA study team

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveWe estimate facility-level average annual costs per client along the HIV testing and counselling (HTC) and prevention of mother-to-child transmission (PMTCT) service cascades.

designData collected covered the period 2011-2012 in 230 HTC and 212 PMTCT facilities in Kenya, Rwanda, South Africa, and Zambia.

methodsInput quantities and unit prices were collected, as were output data. Annual economic costs were estimated from the service providers' perspective using micro-costing. Average annual costs per client in 2013 United States dollars (US$) were estimated along the service cascades.

resultsFor HTC, average cost per client tested ranged from US$5 (SD US$7) in Rwanda to US$31 (SD US$24) in South Africa, whereas average cost per client diagnosed as HIV-positive ranged from US$122 (SD US$119) in Zambia to US$1367 (SD US$2093) in Rwanda. For PMTCT, average cost per client tested ranged from US$18 (SD US$20) in Rwanda to US$89 (SD US$56) in South Africa; average cost per client diagnosed as HIV-positive ranged from US$567 (SD US$417) in Zambia to US$2021 (SD US$3210) in Rwanda; average cost per client on antiretroviral prophylaxis ranged from US$704 (SD US$610) in South Africa to US$2314 (SD US$3204) in Rwanda; and average cost per infant on nevirapine ranged from US$888 (SD US$884) in South Africa to US$2359 (SD US$3257) in Rwanda.

conclusionWe found important differences in unit costs along the HTC and PMTCT service cascades within and between countries suggesting that more efficient delivery of these services is possible.

Indexed as

Health Care CostsAfricaCounselingDiagnostic Tests, RoutineFemaleHIV InfectionsHumansInfectious Disease Transmission, VerticalMaleRetrospective Studies

Identifiers

PMID27753679
PMCPMC5051528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.